111 ROE 2018-2024 | YI

Current and historical return on equity (ROE) values for 111 (YI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
111 ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $-0.05B $-0.09B 58.02%
2024-03-31 $-0.05B $-0.08B 70.90%
2023-12-31 $-0.06B $-0.08B 80.87%
2023-09-30 $-0.04B $-0.07B 65.08%
2023-06-30 $-0.04B $-0.06B 72.41%
2023-03-31 $-0.05B $-0.06B 88.89%
2022-12-31 $-0.06B $-0.06B 124.35%
2022-09-30 $-0.06B $-0.05B 162.03%
2022-06-30 $-0.09B $-0.05B 306.90%
2022-03-31 $-0.10B $-0.04B 869.57%
2021-12-31 $-0.11B $-0.02B -1135.14%
2021-09-30 $-0.11B $-0.01B -354.47%
2021-06-30 $-0.09B $0.03B -170.30%
2021-03-31 $-0.07B $0.05B -113.41%
2020-12-31 $-0.07B $0.06B -90.03%
2020-09-30 $-0.07B $0.07B -76.67%
2020-06-30 $-0.07B $0.08B -66.35%
2020-03-31 $-0.07B $0.10B -58.90%
2019-12-31 $-0.07B $0.11B -51.71%
2019-09-30 $-0.07B $0.13B -42.50%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.052B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00